Wuxi agrees €150 million deal to buy Wuppertal drug substance facility from Bayer
Acquisition will extend the Chinese CDMO’s European footprint and will complement Leverkusen drug product site
Chinese contract development and manufacturing organisation WuXi Biologics has expanded its European footprint, after agreeing to buy and take over Bayer’s drug substance (DS) facility at Wuppertal, Germany in a deal worth around Eur 150 million.
The companies also plan to enter into a long-term sublease agreement and a transition service contract. The transaction, subject to regulatory approval, is expected to close in the first half of 2021.
The 30,000-square-meter facility includes 3x1000L perfusion and 6x2000L fed-batch capacity with independent downstream suites and will complement Wuxi’s drug product facility in Leverkusen as both will be used for commercial manufacturing of OCIVD-19 vaccines and other biologics, Wuxi said.
Bayer will provide services and contribute its own resources as WuXi Biologics ramps up the Wuppertal plant for production.
The two facilities are expected to be ready for drug substance and drug product manufacturing by 2021.
“This new facility will be a key component of our ‘Global Dual Sourcing’ strategy, demonstrating great synergy with our existing network,” said Dr. Chris Chen, CEO of WuXi Biologics.
Back in June, WuXi signed a 10-year lease for a clinical manufacturing facility in Cranbury, New Jersey, its third US site. Earlier in the year it announced plans to build a 107,000-sq. ft clinical and commercial manufacturing facility in Worcester, Massachusetts, and also leased a 33,000-sq. ft site for a process development laboratory in King of Prussia, Pennsylvania.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance